What's Next For Caris Life Sciences (CAI) After 21% Jump?
After soaring by as much as 21.58 percent on Thursday, Caris Life Sciences Inc.
Caris Life Sciences Inc. (CAI)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Coatue Management Philippe Laffont | 9,819,992 | $174,992,258 | 0.36% | |
| 2. | Braidwell LP Alex Karnal | 8,256,032 | $147,122,490 | +4% | 5.44% |
| 3. | Point State Capital Zach Schreiber | 6,828,835 | $121,689,840 | -8% | 1.56% |
| 4. | OrbiMed Advisors Samuel Isaly | 2,806,811 | $50,017,372 | 0.93% | |
| 5. | Millennium Management Israel Englander | 2,202,647 | $39,251,170 | +45% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.56 | 68,000 | $990,080.00 | 704,598 | 2026-05-15 | Filing | |
| $16.15 | 31,050 | $501,426.45 | 49,671 | 2026-05-11 | Filing | |
| $24.09 | 4,184 | $100,792.56 | 9,184 | 2025-11-07 | Filing | |
| $23.85 | 400 | $9,540.00 | 460,777 | 2025-11-07 | Filing | |
| $21.00 | 7,500 | $157,500.00 | 123,591 | 2025-06-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.16 | 1,400 | $38,017.56 | 99,571 | 2025-12-11 | Filing | |
| $26.56 | 60,850 | $1,616,443.74 | 100,971 | 2025-12-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,923,878 | $551,063,502 | 0.02% | |
| 2. | 11,256,615 | $200,592,879 | 100% | |
| 3. | 7,327,041 | $130,567,870 | 22.54% | |
| 4. | 6,558,514 | $120,243,533 | 0.01% | |
| 5. | 5,536,798 | $98,665,739 | 0% |
News See All
12 Best IPO Stocks with Huge Upside Potential
In this article, we will discuss the 12 Best IPO Stocks with Huge Upside Potential.
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Caris Life Sciences, Inc. (NASDAQ:CAI) is one of the most promising stocks on our list.
10 Most Promising Cancer Stocks According to Wall Street Analysts
In this article, we will be taking a look at the 10 Most Promising Cancer Stocks According to Wall Street Analysts.
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CAI.
10 Best New Stocks to Buy With Huge Upside Potential
In this article, we will discuss the 10 Best New Stocks to Buy With the Huge Upside Potential.
Caris Life Sciences, Inc. (NASDAQ:CAI) Q1 2026 Earnings Call Transcript
Caris Life Sciences, Inc. (NASDAQ:CAI) Q1 2026 Earnings Call Transcript May 7, 2026Caris Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.0018, expectations were $-0.02411.
Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth Acceleration
We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Caris Life Sciences, Inc. is among the best biotech stocks.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Right Now.
Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating
Caris Life Sciences Inc. (NASDAQ:CAI) is one of the most oversold healthcare stocks to invest in. Jefferies initiated coverage of Caris Life Sciences Inc.
Hedge Fund Resource Center